This finding is consistent with the finding by Fujimoto et al. [10], who found that anti-TIF1-Ab-positive adults <40 years of age did not suffer from co-existing malignancy, whereas those >40 years of age had a high risk of cancer (75%). This evidence concerns the gene TRIM24 and cancer.